Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New HIV integrase inhibitors discovered by Pfizer researchers

June 16, 2004

Promising effects of the protease inhibitor PL-100 against resistant HIV strains

June 16, 2004

HIV SL9-derived peptides and their use in HIV infection prophylaxis

June 14, 2004

Trimeris and Array BioPharma renew antiviral drug discovery agreement

June 9, 2004

Gilead claims new HIV integrase inhibitors

June 7, 2004

Tripep receives approval to conduct alphaHGA microdosing study

June 7, 2004

Altachem advances phase I trial for ACP-HIP

June 4, 2004

PA-457 completes single-dose phase I trial

June 3, 2004

New phase II trial for Serostim in HARS

June 3, 2004

Novel anti-HIV agent targets RNase H activity

June 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...